BLRX

BioLineRx Ltd

Price

$2.60

return (12m)

-32.29%

p/e

-1.13

p/bv

0.82

DIVIDEND YIELD

0.00%

BLRX price

BioLineRx Ltd

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BLRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.80%

3 months

-16.13%

1 year

-32.29%

2 years

-87.88%

5 years

-97.58%

10 years

-99.62%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BLRX

Valuation

P/E

-1.13

Sector 7.65

Industry 7.65

P/BV

0.82

Sector 1.79

Industry 1.79

P/Revenue (PSR)

1.84

Sector 1.74

Industry 1.74

EV/EBITDA

-0.13

Sector -162.71

Industry -162.71

EV/EBIT

-0.13

Sector -509.92

Industry -509.92

P/EBITDA

-2.68

Sector -12.14

Industry -12.14

P/EBIT

-2.44

Sector -11.16

Industry -11.16

P/Total Assets

0.34

Sector 0.84

Industry 0.84

P/Net Current Assets

-22.11

Sector -1.99

Industry -1.99

P/Working Capital

4.24

Sector -4,793.13

Industry -4,793.13

EPS

-2.25

Sector 0.71

Industry 0.71

BVPS

3.10

Sector 9.75

Industry 9.75

Efficiency

Gross Margin

81.45%

Sector 34.97%

Industry 34.97%

EBITDA Margin

-1,188.78%

Sector -247.12%

Industry -247.12%

EBIT Margin

-1,215.31%

Sector -7.20%

Industry -7.20%

Operating Margin

-100.00%

Sector 4.17%

Industry 4.17%

Net Profit Margins

-100.00%

Sector 2.61%

Industry 2.61%

Asset Turnover

0.01

Sector 0.11

Industry 0.11

Profitability

ROE

-72.65%

Sector 2.32%

Industry 2.32%

ROA

-29.88%

Sector -0.76%

Industry -0.76%

ROIC

Sector -119.29%

Industry -119.29%

Dividends

Dividend yield

0.00%

Sector 0.52%

Industry 0.52%

Payout

Sector 9.75%

Industry 9.75%

Debt

Current Ratio

1.20

Sector 1.47

Industry 1.47

Net Debt / EBITDA

3.05

Sector 1.31

Industry 1.31

Net Debt / EBIT

2.99

Sector -168,249,945.02

Industry -168,249,945.02

Net Debt / Equity

-0.79

Sector -0.77

Industry -0.77

Gross Debt / Equity

0.16

Sector 0.19

Industry 0.19

Equity/Assets

0.41

Sector 0.43

Industry 0.43

Liabilities/Assets

0.50

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-18.04%

Sector -

Industry -

Fundamentals BLRX

DRAG THE FRAME TO SEE MORE DATA

BLRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BioLineRx Ltd

BioLineRx Ltd

Average Investor10 user rating

4.0 (1 people)

United States

- year

Founded:

2011

Time since IPO - 15 years

20

Employees

BioLineRx Ltd (United States) is listed on the Nasdaq and has a market capitalization of $11.32 million, with shareholders equity totaling $13.77 million.

The company employs approximately 20 people and operates in the Others sector, within the Others industry.

Over the past 12 months, BioLineRx Ltd reported $6.15 million in revenue, generating net income of $-10.00 million.

Key financial metrics include a P/E ratio of -1.13, a price-to-book (P/B) ratio of 0.82, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BLRX.

Market cap

$11.32 million

Net worth

$13.77 million

$13,769,900.00

Assets

$33.48 million

$33,479,759.00

Total Shares Outstanding

4.44 million

4,441,000

Average Daily Trading Volume

$59.31 Thousand

$59,308.00

Sector

Others

Industry

Others

BLRX

BLRX revenue and profits

Financial Results BLRX

DRAG THE FRAME TO SEE MORE DATA

BLRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$376.59 12,36% (12M)

P/E

24.17

2.39%

ROE

13.51%

P/BV

3.27

SHEL - Shell PLC ADR

$95.78 35,35% (12M)

P/E

10.28

3.16%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.60 --50,16% (12M)

P/E

-0.52

0.00%

ROE

-35.93%

P/BV

0.19

COR - Cencora Inc.

$306.92 0,73% (12M)

P/E

22.48

0.79%

ROE

81.03%

P/BV

18.21

ALIZY - Allianz SE ADR

$48.37 --14,77% (12M)

P/E

13.35

2.81%

ROE

17.89%

P/BV

2.39

TTE - TotalEnergies SE ADR

$90.94 55,77% (12M)

P/E

7.29

4.46%

ROE

21.42%

P/BV

1.56

NSRGY - Nestle SA ADR

$93.15 8,84% (12M)

P/E

11.20

4.29%

ROE

58.05%

P/BV

6.50

ELV - Elevance Health Inc

$395.92 26,72% (12M)

P/E

19.87

1.71%

ROE

9.84%

P/BV

1.96